MAPKAPK5-AS1 and myositis disease: Abnormal proliferation of B lymphocytes can differentiate into plasma cells and produce higher levels of autoantibodies, especially myositis specific autoantibodies (MSAs) and myositis associated autoantibodies (MAAs), which not only can be used to classify IIMs subtypes, but also to identify IIMs clinical phenotypes (40, 41).